Progressive Therapeutics

Progressive Therapeutics in Acton, Massachusetts provides Spravato (esketamine), the first FDA-approved nasal spray developed specifically for adults with treatment-resistant depression. As a fast-acting treatment, Spravato helps many clients feel relief within hours when traditional antidepressants have not provided enough improvement.

Before starting treatment, each patient completes an initial evaluation with a clinician to determine whether the Spravato program is the right fit. The practice emphasizes individualized psychiatric care delivered in a compassionate environment where every patient feels heard and valued.

In addition to Spravato, the Acton office offers counseling, medication management, and other innovative therapies. Accepted insurance for Spravato includes Blue Cross Blue Shield, Optum, United Healthcare, Point32Health, Harvard Pilgrim, Tufts, and Medicare.